Ekso Bionics raises ~$5.1M net in underwritten public offering of units with warrants

EKSO BIONICS HOLDINGS, INC.

Issued 3.1M units at $1.00/unit (share + Series A/B warrants) and 2.9M pre-funded units at $0.9990/unit.
Net proceeds after underwriting discount and expenses were approximately $5.1 million.
Each Series A and B warrant exercisable at $1.00 per share; pre-funded warrants at $0.001.
Executive officers and directors subject to 90-day lock-up on common stock sales.
Underwriter is Craig-Hallum Capital Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.